Michelle R Menze

Title: Michelle R Menze: Innovator in Pharmaceutical Chemistry

Introduction

Michelle R Menze is a notable inventor based in St. Louis, MO (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel forms of naltrexone hydrochloride. Her work is essential in addressing addictive behaviors through innovative pharmaceutical compositions.

Latest Patents

Michelle R Menze holds 1 patent for her invention titled "Crystalline and amorphous forms of naltrexone hydrochloride." This invention relates to novel crystalline forms of naltrexone hydrochloride, including hydrated and solvated forms, as well as a novel amorphous form. The patent also describes methods for preparing these various crystalline forms and outlines pharmaceutical compositions that contain them. Furthermore, it details methods for treating addictive behavior by administering these pharmaceutical compositions.

Career Highlights

Michelle is currently employed at Mallinckrodt, Inc., where she continues to advance her research and development efforts. Her work at this company has positioned her as a key player in the pharmaceutical industry, particularly in the area of addiction treatment.

Collaborations

Some of her notable coworkers include Gary A Nichols and Anthony Mannino. Their collaborative efforts contribute to the innovative environment at Mallinckrodt, Inc., fostering advancements in pharmaceutical research.

Conclusion

Michelle R Menze's contributions to pharmaceutical chemistry, particularly through her patent on naltrexone hydrochloride, highlight her role as an influential inventor in the field. Her work not only advances scientific knowledge but also has the potential to impact the treatment of addiction significantly.